Abstract
The causative pathogens in diabetic foot infections differ in studies of European compared with Asian populations. The purpose of this study was to determine the causative microorganisms and their antibiotic sensitivity patterns in diabetic patients with a foot infection in Turkey, a country at the crossroads of these two continents. We performed a comprehensive literature search to identify all published studies pertaining to DFIs in patients cared for in Turkey. To assess changes in causative organisms and their antibiotic sensitivity patterns over time, we compared the results of just the most recent 5 years (2007–2011) with those of the past 20-years (1989–2011). We identified 31 studies meeting our inclusion criteria. Overall, these studies reported 2,097 patients, from whom 1,974 microorganisms were isolated. The total percentage of gram-negative and gram-positive aerobic bacteria were similar in each of the assessed periods. The rate of isolation of Staphylococcus aureus during the entire period, compared with just the past 5 years, was 23.8 % and 19.1 %, respectively, while the rate of methicillin-resistant S. aureus was 7.8 % and 5.7 %, respectively. The isolation rate of Pseudomonas aeruginosa was 13.7 % for the entire period and 14.9 % for the past 5 years. While linezolid, vancomycin and teicoplanin were the most active agents against gram-positive microorganisms, imipenem and cefoperazone-sulbactam were the most active against gram-negative microorganisms. This systematic review demonstrated few substantial changes in diabetic foot microbiology over the past 20 years. The data may help develop and update local clinical guidelines regarding antibiotic therapy for diabetic foot infections in Turkey. Further studies, especially with optimal culture methods, would be useful to validate these findings.
Similar content being viewed by others
References
Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87(1):4–14. doi:10.1016/j.diabres.2009.10.007
Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J (2005) The global burden of diabetic foot disease. Lancet 366(9498):1719–1724. doi:10.1016/S0140-6736(05)67698-2
van Battum P, Schaper N, Prompers L, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J, Ferreira I, Huijberts M (2011) Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabet Med 28(2):199–205. doi:10.1111/j.1464-5491.2010.03192.x
Tentolouris N, Jude EB, Smirnof I, Knowles EA, Boulton AJ (1999) Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med 16(9):767–771
Dang CN, Prasad YD, Boulton AJ, Jude EB (2003) Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 20(2):159–161. doi:10.1046/j.1464-5491.2003.00860.x
Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA (2007) Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 45(9):2819–2828. doi:10.1128/JCM.00551-07
Ramakant P, Verma AK, Misra R, Prasad KN, Chand G, Mishra A, Agarwal G, Agarwal A, Mishra SK (2011) Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia 54(1):58–64. doi:10.1007/s00125-010-1893-7
Al Benwan K, Al Mulla A, Rotimi VO (2012) A study of the microbiology of diabetic foot infections in a teaching hospital in Kuwait. J Infect Public Health 5(1):1–8. doi:10.1016/j.jiph.2011.07.004]
Mohanasoundaram KM (2012) The microbiological profile of diabetic foot infections. J Clin Diagn Res 6(3):409–411
Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, Deery HG, Embil JM, Joseph WS, Karchmer AW, Pinzur MS, Senneville E (2012) Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 54(12):e132–173. doi:10.1093/cid/cis346
Umadevi S, Kumar S, Joseph NM, Easow JM, Kandhakumari G, Srirangaraj S, Raj S, Stephen S (2011) Microbiological study of diabetic foot infections. IJMS 2(1):12–17
Shanmugam P, Jeya M, Linda SS (2013) The bacteriology of diabetic foot ulcers, with a special reference to multidrug resistant strains. J Clin Diagn Res 7(3):441–445. doi:10.7860/JCDR/2013/5091.2794
Park SJ, Jung HJ, Shin HK, Kim E, Lim JJ, Yoon JW (2009) Microbiology and antibiotic selection for diabetic foot infections. J Korean Foot Ankle Soc 13(2):150–155
Carvalho CB, Neto RM, Aragao LP, Oliveira MM, Nogueira MB, Forti AC (2004) Pe diabetico: analise bacteriologica de 141 casos (Diabetic foot infection. Bacteriologic analysis of 141 patients.). Arq Bras Endocrinol Metabol 48(3):398–405
Dezfulian A, Salehian MT, Amini V, Dabiri H, Azimi Rad M, Aslani MM, Alebouyeh M, Fazel I, Zali MR (2011) Bacteriological study of diabetic foot infections in an Iranian hospital. Iran Red Crescent Med J 13(8):590–591
Mendes JJ, Marques-Costa A, Vilela C, Neves J, Candeias N, Cavaco-Silva P, Melo-Cristino J (2012) Clinical and bacteriological survey of diabetic foot infections in Lisbon. Diabetes Res Clin Pract 95(1):153–161. doi:10.1016/j.diabres.2011.10.001
Lipsky BA, Holroyd KJ, Zasloff M (2008) Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin Infect Dis 47(12):1537–1545. doi:10.1086/593185
Kandemir O, Akbay E, Sahin E, Milcan A, Gen R (2007) Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms. J Infect 54(5):439–445. doi:10.1016/j.jinf.2006.08.013
Richard JL, Sotto A, Jourdan N, Combescure C, Vannereau D, Rodier M, Lavigne JP (2008) Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers. Diabetes Metab 34(4 Pt 1):363–369. doi:10.1016/j.diabet.2008.02.005
Ertugrul BM, Oncul O, Tulek N, Willke A, Sacar S, Tunccan OG, Yilmaz E, Kaya O, Ozturk B, Turhan O, Yapar N, Ture M, Akin F (2012) A prospective, multi-center study: factors related to the management of diabetic foot infections. Eur J Clin Microbiol Infect Dis 31(9):2345–2352. doi:10.1007/s10096-012-1574-1
Bakker K, Apelqvist J, Schaper NC (2012) Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev 28(Suppl 1):225–231. doi:10.1002/dmrr.2253
Bakker K, Schaper NC (2012) The development of global consensus guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev 28(Suppl 1):116–118. doi:10.1002/dmrr.2254
Lipsky BA, Peters EJ, Berendt AR, Senneville E, Bakker K, Embil JM, Lavery LA, Urbancic-Rovan V, Jeffcoate WJ (2012) Specific guidelines for the treatment of diabetic foot infections 2011. Diabetes Metab Res Rev 28(Suppl 1):234–235. doi:10.1002/dmrr.2251
Blanes JI (2011) Consensus document on treatment of infections in diabetic foot. Rev Esp Quimioter 24(4):233–262
Tan T, Shaw EJ, Siddiqui F, Kandaswamy P, Barry PW, Baker M (2011) Inpatient management of diabetic foot problems: summary of NICE guidance. BMJ 342:d1280. doi:10.1136/bmj.d1280
Société de Pathologie Infectieuse de Langue Française (2007) Management of diabetic foot infections. Long text. Med Mal Infect 37 (1):26–50
Moher D, Liberati A, Tetzlaff J, Altman DG (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336–341. doi:10.1016/j.ijsu.2010.02.007
Akova M, Ozcebe O, Gullu I, Unal S, Gur D, Akalin S, Tokgozoglu M, Telatar F, Akalin HE (1996) Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections. J Chemother 8(4):284–289
Gökel Y (1996) Diyabetik ayak enfeksiyonlarında etyoloji, tedavi ve prognoz (in Turkish). Çukurova University, Adana
Tarhan O, Aker Aİ, Hekimsoy Z, Çömlekçi A, Okan İ, Biberoğlu S, Yeşil S, Araç S, Oto Ö, Gülay Z, Biberoğlu K (1997) Diabetic extremity infections: our clinical experiences. FLORA 3:183–187
Gökalan IK, Çetin B, Yalçın N, Sermez Y (1999) Conservative treatment of diabetic foot infections. Le Infezioni in Medicina 1:39–42
Ulusoy S, Arda B, Bayraktar F, Sesli E, Özinel MA, Yamazhan T, Ünal İ, Kısakol G, Tüzün M (2000) Diabetic foot infections: the evaluation of 179 cases. FLORA 5(4):220–228
Kandemir Ö, Öztuna V, Şahin E, Eskandari MM, Kaya A (2002) Assessment of the severe diabetic foot infections with respect to aerobic microorganisms and clinical aspects. ANKEM Derg 16(4):466–469
Arıkan Ş, Karaahmetoğlu S, Müftüoğlu O (2002) Are increases of fever, white blood cell and erytrocyte sedimentation rate as an indicator for poor prognosis in patients with diabetic foot? Türkiye Tıp Dergisi 9(2):49–54
Uzun G, Solmazgul E, Curuksulu H, Turhan V, Ardic N, Top C, Yildiz S, Cimsit M (2007) Procalcitonin as a diagnostic aid in diabetic foot infections. Tohoku J Exp Med 213 (4):305–312. doi:JST.JSTAGE/tjem/213.305.
Ozkara A, Delibası T, Selcoki Y, Arikan MF (2008) The major clinical outcomes of diabetic foot infections: One center experience. Cent Eur J Med 3(4):464–469
Bezirgan S (2010) Diyabetik ayakta enfeksiyon etkenleri ve antibiyotik duyarlılıkları (in Turkish). Kocaeli University, Kocaeli
Mert G, Metin S, Yýldýz E, Karakuzu E, Çakmak T (2012) Infection agents detected with wound culture in patients with diabetic foot who will undergo hyperbaric oxygen treatment. TAF Prev Med Bull 11(2):205–210
Ata N (2009) The importance of risk factors and microbiological diagnosis in the treatment of diabetic foot infections. Gazi University, Ankara
Örmen B, Türker N, Vardar İ, Coşkun NA, Kaptan F, Ural S, El S, Türker M (2007) Clinical and bacteriological analysis of diabetic foot infections. İnfeksiyon Dergisi (Turkish Journal of Infection) 21(2):65–69
Gündeş S, Yuluğkural Z, Cantürk Z, Bıyıklı M, Çetinarslan B (2007) Evaluation of a diabetic foot protocol: clinical and microbiological data of 68 diabetic patients with deep foot infections, treatment and prognosis. Hastane İnfeksiyonları Dergisi 11(4):246–251
Öztoprak N, Akduman D, Pişkin N, Çelebi G, Aydemir H (2007) Diabetic foot infections: the evaluation of 35 cases. FLORA 12(4):196–200
Şerefhanoğlu K, Turan H, Ergin TF, Arslan H (2006) Aerobic bacteriological analysis of diabetic foot infections. ANKEM Derg 20(2):85–88
Demirci H, Aktürk M, Günal Ö, Güler MÖ, Kandal S, Güner H, Karakoç A, Törüner FB, Arslan M (2006) Microorganisms that cause the infections in diabetic foot patients. MN Dahili Tıp Bilimleri 1(2):85–89
Özaydin Ç, Özaydin I, Acar S, Yavuz TM, Öksüz Ş, Şahin I, Yildirim M, Karaman S (2010) Clinical and aerobic bacteriological analysis of diabetic foot infections. Türk Mikrobiyol Cem Derg 40(2):109–116
Saçar S, Turgut H, Kaleli İ, Toprak S, Demir M, Cenger DH (2008) Pamukkale Üniversitesi Hastanesi’nde diyabetik ayak infeksiyonlarının mikrobiyolojik ve klinik degerlendirmesi. Pamukkale Tıp Dergisi 1:9–12
Açar GK (2006) Diabetik ayakta tedavi yaklaşımları ve wagner sınıflamasının tedaviyi yönlendirmedeki rolü (in Turkish). İstanbul Medeniyet University, İstanbul
Cetin M, Ocak S, Kuvandik G, Aslan B (2007) Comparison of bacterial isolates cultured from hemodialysis patients and other patients with diabetic foot and their antimicrobial resistance. Ren Fail 29(8):973–978. doi:10.1080/08860220701641702
Ertugrul MB, Baktiroglu S, Salman S, Unal S, Aksoy M, Berberoglu K, Calangu S (2008) Pathogens isolated from deep soft tissue and bone in patients with diabetic foot infections. J Am Podiatr Med Assoc 98(4):290–295
Ozer B, Kalaci A, Semerci E, Duran N, Davul S, Yanat AN (2010) Infections and aerobic bacterial pathogens in diabetic foot. Afr J Microbiol Res 4(20):2153–2160
Bozkurt F, Gülsün S, Tekin R, Hosoglu S, Acemoglu H (2011) Comparison of microbiological results of deep tissue biopsy and superficial swab in diabetic foot infections. J Microbiol Infect Dis 1(3):122–127
Saltoglu N, Dalkiran A, Tetiker T, Bayram H, Tasova Y, Dalay C, Sert M (2010) Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital. Clin Microbiol Infect 16(8):1252–1257. doi:10.1111/j.1469-0691.2009.03067.x
Altay FA, Sencan I, Senturk GC, Altay M, Guvenman S, Unverdi S, Acikgoz ZC (2012) Does treatment affect the levels of serum interleukin-6, interleukin-8 and procalcitonin in diabetic foot infection? A pilot study. J Diabetes Complicat 26(3):214–218. doi:10.1016/j.jdiacomp.2012.03.018
Gönen MS, Çakır M, Gönülalan G, Öztürk M, İpekçi SH, Köşker A, Karalezli MN, Erayman I, Durgul K, Keskin M, Seyhan N (2012) The problems and cost-effectiveness analysis of diabetic foot infections. Turk Jem 16:10–13
Akçay S, Satoğlu İS, Harman E, Kurtulmuş A, Kazımoğlu C (2012) A retrospective analysis of amputation rates and comorbidity in patients with diabetic foot ulcer. Med-Science 1(4):331–340
Mutluoglu M, Uzun G, Turhan V, Gorenek L, Ay H, Lipsky BA (2012) How reliable are cultures of specimens from superficial swabs compared with those of deep tissue in patients with diabetic foot ulcers? J Diabetes Complicat 26(3):225–229. doi:10.1016/j.jdiacomp.2012.03.015
Raja NS (2007) Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases. J Microbiol Immunol Infect 40(1):39–44
Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R (2006) A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 29(8):1727–1732. doi:10.2337/dc06-0116
Lipsky BA (2004) Medical treatment of diabetic foot infections. Clin Infect Dis 39(Suppl 2):S104–S114. doi:10.1086/383271
Giordano P, Song J, Pertel P, Herrington J, Kowalsky S (2005) Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection. Int J Antimicrob Agents 26(5):357–365. doi:10.1016/j.ijantimicag.2005.07.017
Eleftheriadou I, Tentolouris N, Argiana V, Jude E, Boulton AJ (2010) Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs 70(14):1785–1797. doi:10.2165/11538070-000000000-00000
Erdem H, Dizbay M, Karabey S, Kaya S, Demirdal T, Koksal I, Inan A, Erayman I, Ak O, Ulu-Kilic A, Karasahin O, Akbulut A, Elaldi N, Yilmaz G, Candevir A, Gul HC, Gonen I, Oncul O, Aslan T, Azak E, Tekin R, Kocak Tufan Z, Yenilmez E, Arda B, Gungor G, Cetin B, Kose S, Turan H, Akalin H, Karabay O, Dogan-Celik A, Albayrak A, Guven T, Celebi G, Ozgunes N, Ersoy Y, Sirmatel F, Oztoprak N, Balkan II, Bayazit FN, Ucmak H, Oncu S, Ozdemir D, Ozturk-Engin D, Bitirgen M, Tabak F, Akata F, Willke A, Gorenek L, Ahmed SS, Tasova Y, Ulcay A, Dayan S, Esen S, Leblebicioglu H, Altun B, Unal S (2013) Withdrawal of Staphylococcus aureus from intensive care units in Turkey. Am J Infect Control 41(11):1053–1058. doi:10.1016/j.ajic.2013.01.041
Noel GJ, Bush K, Bagchi P, Ianus J, Strauss RS (2008) A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections. Clin Infect Dis 46(5):647–655. doi:10.1086/526527
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hatipoglu, M., Mutluoglu, M., Uzun, G. et al. The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review. Eur J Clin Microbiol Infect Dis 33, 871–878 (2014). https://doi.org/10.1007/s10096-014-2047-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-014-2047-5